• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Regulation of ACAT in diabetes and insuliln resistant

Research Project

Project/Area Number 12671118
Research Category

Grant-in-Aid for Scientific Research (C)

Allocation TypeSingle-year Grants
Section一般
Research Field Metabolomics
Research InstitutionKumamoto University

Principal Investigator

MIYAZAKI Akira  Kumamoto University School of Medicine, Department of Biochemistry, Associate Professor, 医学部, 講師 (70253721)

Co-Investigator(Kenkyū-buntansha) HORIUCHI Seikoh  Kumamoto University School of Medicine, Department of Biochemistry, Professor, 医学部, 教授 (10117377)
Project Period (FY) 2000 – 2001
Project Status Completed (Fiscal Year 2001)
Budget Amount *help
¥3,400,000 (Direct Cost: ¥3,400,000)
Fiscal Year 2001: ¥1,400,000 (Direct Cost: ¥1,400,000)
Fiscal Year 2000: ¥2,000,000 (Direct Cost: ¥2,000,000)
KeywordsACAT / macrophage / atherosclerosis / foam cells / cholesterol ester / differentiation
Research Abstract

Regulation of acyl-coenzyme A : cholesterol acyltransferase (ACAT) under various pathological conditions was examined. Mouse macrophage-derived J774 cells are converted to foam cell with acetylated LDL by accumulating cholesterol esters. Addition of glibenclamide, a drug for controlling hyperglycemia in diabetic patients, significantly inhibited cholesterol ester accumulation. ACAT assay in vitro using the extracts of J774 cells demonstrated that glibenclamide acts as an inhibitor for ACAT. Expression of ACAT-1, a major ACAT isozyme in monocyte-macrophages, was induced by 1,25-dihydroxyvitamin D3 or 9-cis-retinoic acid in human monocytic THP-1 cells. ACAT- 1 increases during spontaneous differentiation of human monocyte-macrophages. When human monocyte-macrophages were incubated with an HMG-CoA reductase inhibitor, cerivastatin, ACAT- 1 induction was significantly suppressed. Addition of mevalonate or geranylgeranylpyrophosphate reversed the effect of cerinvastatin, indicating that geranylgeranylation of an unknown protein is involved in ACAT- 1 induction during human monocyte-macrophage differentiation. We finally examined the effects of various cytokmes on ACAT- 1 expression in human monoyte-macrophages during differentiation. Transforming growth factor P further accelerated ACAT 1 induction during monocyte-macrophage differentiation at the mRNA levels.

Report

(3 results)
  • 2001 Annual Research Report   Final Research Report Summary
  • 2000 Annual Research Report
  • Research Products

    (31 results)

All Other

All Publications (31 results)

  • [Publications] Nobutaka Ohgami et al.: "Glibenclamide acts as an inhibitor of acyl-CoA : cholesterol acyltranferase (ACAT) enzyme"Biochemical and Biophysical Research Communications. 277. 417-422 (2000)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2001 Final Research Report Summary
  • [Publications] Kyu Kyu Muang et al.: "Induction of acyl-coenzyme A : cholesterol acyltransferase-1 by 1,25-dihydroxyvitamin D_3 or 9-cis retinoic acid in undifferentiated THP-1 cells"Journal of Lipid Research. 42. 181-187 (2001)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2001 Final Research Report Summary
  • [Publications] Wenqin Zhu et al.: "The role of galectin-3 in endocytosis of advanced glycation end products and modified low density lipoproteins"Biochemical and Biophysical Research Communications. 280. 1183-1188 (2001)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2001 Final Research Report Summary
  • [Publications] Nobutaka Ohgami et al.: "Scavenger receptor class B type I-mediated reverse cholesterol transport is inhibited by advanced glycation endproducts"The Journal of Biological Chemistry. 276. 13348-13358 (2001)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2001 Final Research Report Summary
  • [Publications] Tadashi Jono et al.: "Lectin-like oxidized low density lipoprotein receptor-1 (LOX-1) serves as an endothelial receptor for advanced glycation end products (AGE)"Federation of European Biochemical Society Letters. 511. 170-174 (2002)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2001 Final Research Report Summary
  • [Publications] Ohgami, N. et al.: "Glibenclamide acts as an inhibitor of acyl-CoA : cholesterol acyltranferase (ACAT) enzyme"Biochem. Bioptys. Res. Commun.. 277. 417-422 (2000)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2001 Final Research Report Summary
  • [Publications] Maung, K. K. et al.: "Induction of acyl-coenzyme A : cholesterol acyltransferase-1 by 1,25-dihydroxyvitamin D3 or 9-cis retinoic acid in undifferentiated THP-1 cells"J. Lipid Res.. 42. 181-187 (2001)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2001 Final Research Report Summary
  • [Publications] Zhu W. et al.: "The role of galectin-3 in endocytosis of advanced glycation end products and modified low density lipoproteins"Biochem. Bioptys. Res. Commun.. 280. 1183-1188 (2001)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2001 Final Research Report Summary
  • [Publications] Ohgami, N. et al.: "Scavenger receptor class B type I-mediated reverse cholesterol transport is inhibited by advanced glycation endproucts"J. Biol. Chem.. 276. 13348-13358 (2001)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2001 Final Research Report Summary
  • [Publications] Jono, T. et al.: "Lectin-like oxidized low density lipoprotein receptor-1 (LOX-1) serves as an endothelial receptor for advanced glycation end products (AGE)"FEBS Lett.. 511. 170-174 (2002)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2001 Final Research Report Summary
  • [Publications] Ohgami N. et al.: "Scavenger receptor class B type I-mediated reverse cholesterol transport is inhibited by advanced glycation endproducts"The Journal of Biological Chemistry. 276. 13348-13355 (2001)

    • Related Report
      2001 Annual Research Report
  • [Publications] Chang T.Y.et al.: "Roles of acyl-coenzyme A : cholesterol acyltransferase-1 and-2"Current Opinion in Lipidology. 12. 289-296 (2001)

    • Related Report
      2001 Annual Research Report
  • [Publications] Jono T.et al.: "Lectin-like oxidized low density lipoprotein-1 (LOX-1) serves as an endothelial receptor for advanced glycation end products (AGE)"Federation of European Biochemical Society Letters. 511. 170-174 (2002)

    • Related Report
      2001 Annual Research Report
  • [Publications] 宮崎 章ほか: "ACATと動脈硬化"診断と治療. 89. 985-990 (2001)

    • Related Report
      2001 Annual Research Report
  • [Publications] 宮崎 章ほか: "マクロファージからみた動脈硬化発症機構"現代医療. 33. 2999-3005 (2001)

    • Related Report
      2001 Annual Research Report
  • [Publications] 宮崎 章ほか: "Acyl-coenzyme A : cholesterol acyltransferase (ACAT)"日本臨床. 59(増刊号2). 219-223 (2001)

    • Related Report
      2001 Annual Research Report
  • [Publications] 宮崎 章ほか: "マクロファージ泡沫化の分子機構"日本臨床. 59(増刊号2). 591-595 (2001)

    • Related Report
      2001 Annual Research Report
  • [Publications] 宮崎 章ほか: "マクロファージにおける脂質代謝異常"日本臨床. 59(増刊号2). 451-156 (2001)

    • Related Report
      2001 Annual Research Report
  • [Publications] 宮崎 章ほか: "ACAT阻害剤"日本臨床. 59(増刊号2). 675-680 (2001)

    • Related Report
      2001 Annual Research Report
  • [Publications] Naomi Sakashita et al.: "Localization of human acyl-coenzymc A : cholesterolacyltransferase-1 (ACAT-1) in macrophages and various tissues."American Journal of Pathology. 156. 227-236 (2000)

    • Related Report
      2000 Annual Research Report
  • [Publications] Takeshi Biwa et al.: "Sites of action of protein kinase C and phosphatidylinositol 3-kinase are distinct in oxidized low density lipoprotein-induced macrophage proliferation."The Journal of Biological Chemistry. 275. 5810-5816 (2000)

    • Related Report
      2000 Annual Research Report
  • [Publications] Nobutaka Ohgami et al.: "Glibenclamide acts as an inhibitor of acyl-coenzyme A : cholesterol acyltransferase (ACAT) enzyme."Biochemical and Biophysical Research Communications. 277. 417-422 (2000)

    • Related Report
      2000 Annual Research Report
  • [Publications] Akira Miyazaki et al.: "Granulocyte macrophage clony-stimulating factor plays a priming role in murine macrophage growth induced by oxidized low density lipoprotein."Annals of New Tork Academy of Sciences. 902. 342-346 (2000)

    • Related Report
      2000 Annual Research Report
  • [Publications] Masakazu Sakai et al.: "Macrophage proliferation in atherosclerosis."Current Opinion in Lipidology. 11. 503-509 (2000)

    • Related Report
      2000 Annual Research Report
  • [Publications] Kyu Kyu Maung et al.: "Induction of acyl-coenzyme A : cholesterol acyltransferase-1 by 1,25-dihydroxyvitamin D3 or 9-cis retinoic acid in undifferentiated THP-1 cells."Journal of Lipid Research. 42. 181-187 (2001)

    • Related Report
      2000 Annual Research Report
  • [Publications] Wen-Qin Zhu et al.: "The role of galectin-3 in endocytosis of advanced glycation endproducts and modified low density lipoproteins."Biochemical and Biophysical Research Communicatins. 280. 1183-1188 (2001)

    • Related Report
      2000 Annual Research Report
  • [Publications] Nobutaka Ohgami et al.: "Scavenger receptor class B type I-mediated reverse cholesterol transport is inhibited by advanced glycation endproducts."The Journal of Biological Chemistry. 276in press. (2001)

    • Related Report
      2000 Annual Research Report
  • [Publications] 宮崎章 ほか: "ACAT"The Lipid. 11(4). 331-336 (2000)

    • Related Report
      2000 Annual Research Report
  • [Publications] 宮崎章 ほか: "動脈硬化病変におけるacyl-coenzyme A : cholesterol acyltransferase (ACAT)の発現調節機構"動脈硬化. 27(6). 141-144 (2000)

    • Related Report
      2000 Annual Research Report
  • [Publications] 宮崎章: "泡沫細胞の形成とACAT"循環器科. 48. 194-196 (2000)

    • Related Report
      2000 Annual Research Report
  • [Publications] 宮崎章 ほか: "ACATと細胞内脂質代謝"Modern Physician. 20(10). 1303-1306 (2000)

    • Related Report
      2000 Annual Research Report

URL: 

Published: 2000-04-01   Modified: 2016-04-21  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi